ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 168 filers reported holding ANIKA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,756 | -9.4% | 108,793 | -9.2% | 0.00% | -33.3% |
| Q1 2024 | $3,043 | -39.6% | 119,819 | -46.2% | 0.00% | -40.0% |
| Q4 2023 | $5,042 | +94.5% | 222,510 | +59.9% | 0.01% | +66.7% |
| Q3 2023 | $2,592 | -99.8% | 139,114 | +365.2% | 0.00% | +200.0% |
| Q4 2021 | $1,072,000 | -15.2% | 29,906 | +0.7% | 0.00% | -50.0% |
| Q3 2021 | $1,264,000 | -41.7% | 29,696 | -40.7% | 0.00% | -33.3% |
| Q2 2021 | $2,167,000 | +21.8% | 50,061 | +6.2% | 0.00% | 0.0% |
| Q2 2020 | $1,779,000 | -21.1% | 47,155 | -39.5% | 0.00% | -50.0% |
| Q1 2020 | $2,255,000 | -79.0% | 77,990 | -62.3% | 0.01% | -76.0% |
| Q4 2019 | $10,736,000 | +138.3% | 207,060 | +152.2% | 0.02% | +127.3% |
| Q3 2019 | $4,506,000 | +40.7% | 82,087 | +4.1% | 0.01% | +57.1% |
| Q2 2019 | $3,203,000 | +77.8% | 78,863 | +32.4% | 0.01% | +75.0% |
| Q1 2019 | $1,801,000 | – | 59,563 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Portolan Capital Management | 217,105 | $10,058,000 | 2.20% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 284,393 | $13,175,000 | 0.88% |
| AMI ASSET MANAGEMENT CORP | 183,494 | $8,501,000 | 0.84% |
| CAPITAL MANAGEMENT CORP /VA | 49,765 | $2,306,000 | 0.74% |
| TFS CAPITAL LLC | 105,839 | $4,904,000 | 0.39% |
| Baltimore-Washington Financial Advisors, Inc. | 24,390 | $1,130,000 | 0.35% |
| OBERWEIS ASSET MANAGEMENT INC/ | 27,600 | $1,279,000 | 0.32% |
| Stephens Investment Management Group LLC | 192,650 | $8,925,000 | 0.27% |
| THOMPSON SIEGEL & WALMSLEY LLC | 263,622 | $12,214,000 | 0.24% |
| DIKER MANAGEMENT LLC | 21,200 | $982,000 | 0.22% |